India Endomyocardial Biopsy Market Size & Outlook, 2025-2030
Related Markets
India endomyocardial biopsy market highlights
- The India endomyocardial biopsy market generated a revenue of USD 13.0 million in 2024 and is expected to reach USD 24.4 million by 2030.
- The India market is expected to grow at a CAGR of 11.1% from 2025 to 2030.
- In terms of segment, forceps was the largest revenue generating product in 2024.
- Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
Endomyocardial biopsy market data book summary
| Market revenue in 2024 | USD 13.0 million |
| Market revenue in 2030 | USD 24.4 million |
| Growth rate | 11.1% (CAGR from 2025 to 2030) |
| Largest segment | Forceps |
| Fastest growing segment | Forceps |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Forceps, Accessories |
| Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
Other key industry trends
- In terms of revenue, India accounted for 3.6% of the global endomyocardial biopsy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan endomyocardial biopsy market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 24.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endomyocardial Biopsy Market Scope
Endomyocardial Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fehling Instruments | View profile | 11-50 | Karlstein, Bayern, Germany, Europe | https://www.fehling-instruments.de |
| Changzhou Lookmed Medical Instrument Co. | View profile | 51-100 | Changzhou, Zhejiang, China, Asia | http://www.lookmedchina.com |
| Scholten Surgical Instruments | View profile | 1-10 | Lodi, California, United States, North America | https://www.novatome.com |
| Argon Medical Devices | View profile | 1001-5000 | Plano, Texas, United States, North America | http://www.argonmedical.com/ |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
India endomyocardial biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 79.23% in 2024. Horizon Databook has segmented the India endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
The gradual adoption of technologically advanced products and increasing awareness among people regarding the treatment of cardiac diseases are projected to promote market growth over the forecast period.
The presence of several local players in India further aids the country in securing a strong market position. India also has world-class technologies, doctors, and clinics, which can subsequently boost the demand for endomyocardial biopsy.
Reasons to subscribe to India endomyocardial biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India endomyocardial biopsy market databook
-
Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India endomyocardial biopsy market , including forecasts for subscribers. This country databook contains high-level insights into India endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India endomyocardial biopsy market size, by product, 2018-2030 (US$M)
India Endomyocardial Biopsy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
